Abstract Aims To investigate Group B Streptococcus (GBS) colonization in pregnancy;
adherence to antenatal GBS screening and adherence to the intrapartum antibiotics protocol …

Background GBS is the leading cause of morbidity and mortality from neonatal sepsis in the
UK and patient groups are keen for screening to be implemented. Intrapartum antibiotic …

Background Against a background of failure to prevent neonatal invasive early-onset group
B Streptococcus infections (GBS) in our maternity unit using risk-based approach for …

Aim. To determine awareness, knowledge and attitudes of lead maternity carers (LMCs)
towards early-onset neonatal group B streptococcus (GBS) infection and its prevention …

Objective To assess the incidence of maternal group B Streptococcus (GBS) infection in
England. Design Population surveillance augmented through data linkage. Setting England …

The approach to the prevention of early onset GBS disease in the newborn varies
considerably from country to country. The Centre for Disease Control in the United States …

Group B streptococcus (GBS) is the leading infectious cause of morbidity and mortality in
Australian newborns. Although intrapartum chemoprophylaxis is recommended to reduce …

Group B streptococcus (GBS) is the most common cause of sepsis and meningitis in infants
under the age of 3 months with a 10% mortality and significant morbidity for many survivors …

Objective To evaluate how UK maternity unit protocols conformed to national
recommendations for preventing early-onset neonatal Group B Streptococcal (GBS) …

A cross-sectional study was conducted at a Thai university hospital between November
2016 and March 2017 to evaluate the prevalence and risk factors of group B Streptococcus …